CN101160524A - 用于生物样品分类的组合物和方法 - Google Patents

用于生物样品分类的组合物和方法 Download PDF

Info

Publication number
CN101160524A
CN101160524A CNA2006800126573A CN200680012657A CN101160524A CN 101160524 A CN101160524 A CN 101160524A CN A2006800126573 A CNA2006800126573 A CN A2006800126573A CN 200680012657 A CN200680012657 A CN 200680012657A CN 101160524 A CN101160524 A CN 101160524A
Authority
CN
China
Prior art keywords
binding activity
epitopes
samples
type
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800126573A
Other languages
English (en)
Chinese (zh)
Inventor
T·纽曼
M·波尔德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CeMines Inc
Original Assignee
CeMines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CeMines Inc filed Critical CeMines Inc
Publication of CN101160524A publication Critical patent/CN101160524A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNA2006800126573A 2005-02-24 2006-02-24 用于生物样品分类的组合物和方法 Pending CN101160524A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
US60/656,859 2005-02-24

Publications (1)

Publication Number Publication Date
CN101160524A true CN101160524A (zh) 2008-04-09

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800126573A Pending CN101160524A (zh) 2005-02-24 2006-02-24 用于生物样品分类的组合物和方法

Country Status (11)

Country Link
US (1) US20090075832A1 (https=)
EP (1) EP1859266A4 (https=)
JP (1) JP2008532014A (https=)
KR (1) KR20080003321A (https=)
CN (1) CN101160524A (https=)
AU (1) AU2006216683A1 (https=)
CA (1) CA2598889A1 (https=)
IL (1) IL185458A0 (https=)
MX (1) MX2007010349A (https=)
RU (1) RU2007135030A (https=)
WO (1) WO2006091734A2 (https=)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171340A (zh) * 2008-08-01 2011-08-31 肿瘤疗法科学股份有限公司 Melk表位肽及包含它的疫苗
CN102822193A (zh) * 2010-01-25 2012-12-12 肿瘤疗法科学股份有限公司 修饰的melk肽及包含它们的疫苗
CN108184330A (zh) * 2015-06-26 2018-06-19 加利福尼亚大学董事会 抗原肽及其用于诊断和治疗自闭症的用途
CN108779149A (zh) * 2016-03-16 2018-11-09 伊玛提克斯生物技术有限公司 用于非小细胞肺癌和其他癌症免疫治疗的肽和肽组合物
CN108948184A (zh) * 2017-05-22 2018-12-07 广东香雪精准医疗技术有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697A (zh) * 2017-08-17 2019-03-01 广东香雪精准医疗技术有限公司 一种识别prame抗原短肽的tcr及其相关组合物
CN110922492A (zh) * 2019-12-18 2020-03-27 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678A (zh) * 2020-02-21 2020-06-26 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842480B2 (en) 2001-05-18 2010-11-30 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
ES2444695T3 (es) * 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
WO2008053573A1 (fr) * 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2201024A1 (en) * 2007-08-28 2010-06-30 Ramot At Tel Aviv University Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CA2740900C (en) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
GB0823366D0 (en) 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
CN105911275B (zh) 2009-08-14 2018-06-29 加利福尼亚大学董事会 诊断自闭症的试剂盒
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
US10060911B2 (en) * 2011-08-19 2018-08-28 Protagen Aktiengesellschaft Method for diagnosis of high-affinity binders and marker sequences
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) * 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
US20150335679A1 (en) * 2014-05-20 2015-11-26 Kiromic, Llc Methods and Compositions for Treating Malignancies with Dendritic Cells
JP7001474B2 (ja) 2015-01-21 2022-01-19 インヒブルクス，インコーポレイティド 非免疫原性単一ドメイン抗体
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
CA2991634C (en) 2015-07-16 2026-03-17 Inhibrx Biosciences, Inc. Multivalent and multispecific dr5-binding fusion proteins
PH12022551111A1 (en) 2015-10-05 2023-08-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
SI3573647T1 (sl) * 2017-01-27 2023-07-31 Immatics Biotechnologies Gmbh Peptidi in kombinacija peptidov za uporabo v imunoterapiji proti raku jajčnikov in drugim oblikam raka
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
EP3999525A4 (en) * 2019-07-15 2023-08-09 Geisinger Health System COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST CANCER WITH A NOVEL CAPER ALPHA MLL1 COMPLEX

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
EP1337667A2 (en) * 2000-11-16 2003-08-27 Cedars-Sinai Medical Center Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
EP1410037A2 (de) * 2001-03-10 2004-04-21 Affina Immuntechnik GmbH Verfahren zur identifikation von immunreaktiven epitopen auf proteinen und verwendung der epitope zu prophylaktischen und therapeutischen zwecken
AU2002256168B2 (en) * 2001-04-10 2007-09-20 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
CA2460959A1 (en) * 2001-09-28 2003-05-22 Incyte Genomics, Inc. Enzymes
WO2004058972A1 (de) * 2002-12-23 2004-07-15 Thiesen Hans-Juergen Human-autoantigene und deren verwendung
JP2006524035A (ja) * 2002-12-26 2006-10-26 シーマインズ リミテッド ライアビリティ カンパニー 癌の診断、予後診断および治療のための方法および組成物

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102171340A (zh) * 2008-08-01 2011-08-31 肿瘤疗法科学股份有限公司 Melk表位肽及包含它的疫苗
US8674069B2 (en) 2008-08-01 2014-03-18 Oncotherapy Science, Inc. MELK epitope peptides and vaccines containing the same
US9193765B2 (en) 2008-08-01 2015-11-24 Oncotherapy Science, Inc. Melk epitope peptides and vaccines containing the same
CN102171340B (zh) * 2008-08-01 2016-12-21 肿瘤疗法科学股份有限公司 Melk表位肽及包含它的疫苗
US9675680B2 (en) 2008-08-01 2017-06-13 OncoTherapy Science MELK epitope peptides and vaccines containing the same
CN102822193A (zh) * 2010-01-25 2012-12-12 肿瘤疗法科学股份有限公司 修饰的melk肽及包含它们的疫苗
US8871719B2 (en) 2010-01-25 2014-10-28 Oncotherapy Science, Inc. Modified MELK peptides and vaccines containing the same
CN102822193B (zh) * 2010-01-25 2016-03-30 肿瘤疗法科学股份有限公司 修饰的melk肽及包含它们的疫苗
CN108184330A (zh) * 2015-06-26 2018-06-19 加利福尼亚大学董事会 抗原肽及其用于诊断和治疗自闭症的用途
CN108779149A (zh) * 2016-03-16 2018-11-09 伊玛提克斯生物技术有限公司 用于非小细胞肺癌和其他癌症免疫治疗的肽和肽组合物
CN108948184A (zh) * 2017-05-22 2018-12-07 广东香雪精准医疗技术有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697A (zh) * 2017-08-17 2019-03-01 广东香雪精准医疗技术有限公司 一种识别prame抗原短肽的tcr及其相关组合物
CN110922492A (zh) * 2019-12-18 2020-03-27 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678A (zh) * 2020-02-21 2020-06-26 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Also Published As

Publication number Publication date
US20090075832A1 (en) 2009-03-19
AU2006216683A1 (en) 2006-08-31
JP2008532014A (ja) 2008-08-14
EP1859266A4 (en) 2010-07-28
WO2006091734A3 (en) 2007-02-08
WO2006091734A2 (en) 2006-08-31
EP1859266A2 (en) 2007-11-28
WO2006091734A9 (en) 2006-10-19
IL185458A0 (en) 2008-01-06
KR20080003321A (ko) 2008-01-07
CA2598889A1 (en) 2006-08-31
MX2007010349A (es) 2008-04-09
RU2007135030A (ru) 2009-03-27

Similar Documents

Publication Publication Date Title
CN101160524A (zh) 用于生物样品分类的组合物和方法
Farlow et al. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non–small cell lung cancer
Broodman et al. Serum protein markers for the early detection of lung cancer: a focus on autoantibodies
Lacombe et al. Use of autoantibodies to detect the onset of breast cancer
Zhong et al. Using protein microarray as a diagnostic assay for non–small cell lung cancer
CN102749447B (zh) 改进的免疫测定方法
US20080081339A1 (en) Tumor associated markers in the diagnosis of prostate cancer
Adeola et al. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort
US20120100558A1 (en) Lung cancer diagnosis
EP2951592A1 (en) Autoantibody signature for the early detection of ovarian cancer
Pei et al. Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer
JP2010507069A (ja) 肺癌診断アッセイ
Pin et al. Identification of a novel autoimmune peptide epitope of prostein in prostate cancer
EP3230745A1 (en) Plasma autoantibody biomarkers for basal like breast cancer
JP2020515826A (ja) 抗体アッセイ
WO2010108638A9 (en) Tumour gene profile
WO2020069661A1 (en) Serological biomarkers for early diagnosis of lung cancer
CN103245784A (zh) 肺癌的诊断分析法
JP6674889B2 (ja) 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ
JP2012531581A (ja) 癌の検出のための方法およびシステム
Luo et al. High‐throughput and multi‐phases identification of autoantibodies in diagnosing early‐stage breast cancer and subtypes
GB2478734A (en) Auto-antibody biomarkers of prostate cancer
CN103257227B (zh) 改进的免疫测定方法
CN113702636B (zh) 血浆自身抗体标志物在乳腺癌早期诊断及其分子亚型表征中的应用
HK1120108A (en) Compositions and methods for classifying biological samples

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1120108

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080409

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1120108

Country of ref document: HK